Who
Vijay Aggarwal
Director
Company insider
Files Form 4 as: Director, Interpace Biosciences.
In numbers
- Trades disclosed
- 3
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 1 Feb 2022
- Last trade
- 20 Aug 2026
- Last filed
- 20 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Aug 2026filed 20 Aug 2026 | Interpace Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —69,252 at $0.00 | filing |
| 20 Aug 2026filed 20 Aug 2026 | Interpace Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —69,252 at $0.00 | filing |
| 1 Feb 2022filed 2 Feb 2022 | Interpace Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —28,000 at $0.00 | filing |
News
Advocate Vijay Aggarwal charged with rape and sexual assault in London. Here are his famous clients...legallyindia.com · 11 Oct 2026Vijay Aggarwal Rape Charges: Indian Lawyer Accused In UK Exploitation Caserediff.com · 9 Oct 2026UK judge refuses bail to Indian lawyer Vijay Aggarwal, accused of sexual assault and human traffickingindiatimes.com · 23 Sep 2026Mehul Choksi's lawyer Vijay Aggarwal denied bail by UK court in sexual assault casestribuneindia.com · 23 Sep 2026Mehul Choksi lawyer Vijay Aggarwal faces allegation of rape, UK court toldtribuneindia.com · 10 Sep 2026
5 headlines in the last 90 days name Vijay Aggarwal; no company of theirs resolves to a name we track.
Sectors
No trade we could place in a sector.